Rondo Therapeutics
PrivateLast Round
Series A
Mar 2, 2022
Total Funding Raised
$67M
Company Overview
Rondo Therapeutics is a biotechnology company that develops bispecific therapeutic antibodies aimed at modulating immune system activation to combat cancer, particularly in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rondo Therapeutics Comparables
Compare Rondo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marengo Therapeutics | 82% | |
| Amgen | 75% | |
| Aktis Oncology | 73% | |
Rondo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 2, 2022 |
Key People
Founding team and executive leadership
Rondo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A |
| Novo Holdings | Series A |
| Canaan Partners | Series A |
| Red Tree Venture Capital | Series A |
| Johnson & Johnson Innovation – JJDC | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Advanced first oncology asset into clinical trials in 2025.
- Mar 2, 2022
$67M Series A round completed.
Rondo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rondo Therapeutics's valuation, stock price, and market status.